Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
作者信息
van Dorp Jeroen, Pipinikas Christodoulos, Suelmann Britt B M, Mehra Niven, van Dijk Nick, Marsico Giovanni, van Montfoort Maurits L, Hackinger Sophie, Braaf Linde M, Amarante Tauanne, van Steenis Charlaine, McLay Kirsten, Daletzakis Antonios, van den Broek Daan, van de Kamp Maaike W, Hendricksen Kees, de Feijter Jeantine M, Boellaard Thierry N, Meijer Richard P, van der Heijden Antoine G, Rosenfeld Nitzan, van Rhijn Bas W G, Jones Greg, van der Heijden Michiel S
机构信息
Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Dutch Uro-Oncology Study Group, Bilthoven, The Netherlands.
出版信息
Nat Med. 2024 Jan;30(1):304. doi: 10.1038/s41591-023-02500-7.
PMID:37460757
Abstract
摘要
Zotero 插件